Completed NA INTERVENTIONAL 3-arm NCT01568788

Post-marketing Clinical Observation of an Inactivated Influenza Split Vaccine

Post-marketing Clinical Observation of Hualan's Inactivated Influenza Vaccine: A Single Center, Parallelled, Controlled, Randomised Clinical Trial

Sponsor: Hualan Biological Engineering, Inc.

Conditions Human Influenza

Interventions Inactivated Influenza Vaccine Inactivated Influenza Vaccine of GSK Inactivated Influenza Vaccine of Pasteur

Updated 5 times since 2017 Last updated: Jun 18, 2012 Started: Dec 31, 2008 Primary completion: Jan 31, 2009 Completion: Mar 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Human Influenza, this trial is completed. The trial is conducted by Hualan Biological Engineering, Inc. and has accumulated 5 data snapshots since 2008. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Dec 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hualan Biological Engineering, Inc.

Data source: Hualan Biological Engineering, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Mianyang, China